Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Clinical trial NCT03587805 · COMPLETED
Trial details
- NCT number
- NCT03587805
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-18
- Primary completion
- 2024-07-03
- Enrollment
- 1672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.